Gene Therapy Products

Reversing Ischemia with Gene therapy

Articles, Business Consultant, DelveInsight's Indication Pipeline Reports, Gene Therapy Products, Pharma Consultant, Venous Thromboembolism

A human body comprises of many small, long, narrow and broad blood vessels that carry oxygenated blood from the heart to other body parts...

Read More

Notizia

Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Gene Therapy Products, Notizia, Pharma Consultant

FDA discards depression drug ALKS 5461 of Alkermes The FDA has rejected approval for ALKS 5461 of Alkermes in major depressive disorder....

Read More

66 Year Ohio Woman Becomes Cancer Free, Thanks to CAR T Cell Therapy

Articles, Business Consultant, DelveInsight's Drug Report, Gene Therapy Products, Pharma Consultant

In a groundbreaking clinical trial, a 66-year-old Ohio woman became the first patient to become cancer free through the CAR T Cell Therapy....

Read More

Notizia

Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, DelveInsight's Oncology based Reports, Gene Therapy Products, Notizia, Pharma Consultant

FDA approves transthyretin amyloidosis therapy of Akcea, Ionis Patients with an orphan, hereditary disease that is transthyretin...

Read More

Biologic Parallel – A Perky Future Ahead

Articles, Business Consultant, Gene Therapy Products, Pharma Consultant

A biosimilar (copycat version) is a pharmaceutical product that is close, but not identical, copy of an approved biologic branded product....

Read More
Close